Levofloxacin N-oxide
CAS No. 117678-38-3
Levofloxacin N-oxide( —— )
Catalog No. M28153 CAS No. 117678-38-3
Levofloxacin N-oxide is an impurity isolated from levofloxacin.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 87 | In Stock |
|
| 2MG | 37 | In Stock |
|
| 5MG | 65 | In Stock |
|
| 10MG | 102 | In Stock |
|
| 25MG | 169 | In Stock |
|
| 50MG | 231 | In Stock |
|
| 100MG | 323 | In Stock |
|
| 200MG | 454 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLevofloxacin N-oxide
-
NoteResearch use only, not for human use.
-
Brief DescriptionLevofloxacin N-oxide is an impurity isolated from levofloxacin.
-
DescriptionLevofloxacin N-oxide is an impurity isolated from levofloxacin.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor5-HT4
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number117678-38-3
-
Formula Weight377.4
-
Molecular FormulaC18H20FN3O5
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESFC1=C(N2CCN(CC2)(C)=O)C(OC[C@H](C)N3C=C(C(O)=O)C4=O)=C3C4=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Tadayoshi Mikami, et al. 5-Amino-6-chloro-N-[(1-isobutylpiperidin-4-yl)methyl]-2-methylimidazo[1,2-alpha]pyridine-8-carboxamide (CJ-033,466), a novel and selective 5-hydroxytryptamine4 receptor partial agonist: pharmacological profile in vitro and gastroprokinetic effect in conscious dogs. J Pharmacol Exp Ther. 2008 Apr;325(1):190-9.
molnova catalog
related products
-
PACMA 31
PACMA 31 is an irreversible and covalent inhibitor of protein disulfide isomerase (PDI) with an IC50 of 10 μM. PACMA 31 significantly suppresses ovarian tumor growth and exhibits tumor targeting ability.
-
Amprolium
Amprolium? is a coccidiostat used in poultry, is a thiamine analogue and blocks the thiamine transporter of Eimeria species by blocking thiamine uptake it prevents carbohydrate synthesis.
-
Setrobuvir
Setrobuvir (ANA-598) is an orally active non-nucleoside HCV NS5B polymerase inhibitor with inhibitory effects on de novo RNA synthesis and primer extension with IC50s between 4 and 5 nM.
Cart
sales@molnova.com